Ilan Guedj

Bates White, LLC

2001 K St., NW

Suite 700

Washington, DC 20006

United States

http://www.bateswhite.com/professionals-Ilan-Guedj.html

SCHOLARLY PAPERS

7

DOWNLOADS
Rank 5,044

SSRN RANKINGS

Top 5,044

in Total Papers Downloads

6,542

CITATIONS
Rank 6,012

SSRN RANKINGS

Top 6,012

in Total Papers Citations

84

Scholarly Papers (7)

1.

Are ETFs Replacing Index Mutual Funds?

AFA 2009 San Francisco Meetings Paper
Number of pages: 41 Posted: 24 Mar 2008 Last Revised: 17 Nov 2009
Jennifer C. Huang and Ilan Guedj
University of Texas at Austin - Department of Finance and Bates White, LLC
Downloads 2,305 (3,419)
Citation 9

Abstract:

ETF, Index Mutual Fund, Transaction Costs

2.

Director Networks

EFA 2007 Ljubljana Meetings Paper
Number of pages: 52 Posted: 01 Mar 2007 Last Revised: 18 Mar 2009
Ilan Guedj and Amir Barnea
Bates White, LLC and HEC Montreal
Downloads 1,201 (10,348)
Citation 17

Abstract:

Executive compensation, Networks, Directors, Corporate Governance

3.

Can Mutual Fund Families Affect the Performance of Their Funds?

EFMA 2004 Basel Meetings Paper
Number of pages: 44 Posted: 06 May 2004
Ilan Guedj and Jannette Papastaikoudi
Bates White, LLC and Integrated Finance LTD
Downloads 1,118 (12,518)
Citation 28

Abstract:

Mutual Funds, Mutual Fund Families, Performance Persistence, Organizational Structure

Ownership Vs. Contract: How Vertical Integration Affects Investment Decisions in Pharmaceutical R&D

McCombs Research Paper Series No. FIN-01-06, AFA 2006 Boston Meetings Paper
Number of pages: 56 Posted: 07 Mar 2005 Last Revised: 08 Feb 2014
Ilan Guedj
Bates White, LLC
Downloads 376 (60,148)
Citation 6

Abstract:

Vertical Integration, Investment Decisions, Internal Capital Markets, Pharmaceutical Industry

Ownership vs. Contract: How Vertical Integration Affects Investment Decisions in Pharmaceutical R&D

EFA 2005 Moscow Meetings Paper
Number of pages: 48 Posted: 28 Feb 2005
Ilan Guedj
Bates White, LLC
Downloads 168 (140,919)
Citation 6

Abstract:

Vertical Integration, Investment Decisions, Internal Capital Markets, Pharmaceutical Industry

Internal Capital Allocation and Firm Performance

Number of pages: 49 Posted: 22 Mar 2009 Last Revised: 18 Mar 2010
Bates White, LLC, University of Texas at Austin - Department of Finance and National University of Singapore (NUS) - Department of Finance
Downloads 325 (71,446)

Abstract:

internal capital allocation, firm performance, stock return

Internal Capital Allocation and Firm Performance

Number of pages: 49 Posted: 15 Jan 2009 Last Revised: 17 Jan 2010
Bates White, LLC, University of Texas at Austin - Department of Finance and National University of Singapore (NUS) - Department of Finance
Downloads 156 (150,401)

Abstract:

internal capital allocation, firm performance, stock return

Organizational Scope and Investment: Evidence from the Drug Development Strategies and Performance of Biopharmaceutical Firms

Number of pages: 47 Posted: 19 Nov 2004
Ilan Guedj and David S. Scharfstein
Bates White, LLC and Harvard Business School - Finance Unit
Downloads 285 (82,899)
Citation 24

Abstract:

Internal capital markets, resource allocation, drug development, financial resources

Organizational Scope and Investment: Evidence from the Drug Development Strategies and Performance of Biopharmaceutical Firms

NBER Working Paper No. w10933
Number of pages: 48 Posted: 14 Dec 2004
Ilan Guedj and David S. Scharfstein
Bates White, LLC and Harvard Business School - Finance Unit
Downloads 66 (275,954)
Citation 24

Abstract:

7.

The Anatomy of Principal Protected Absolute Return Notes

Journal of Derivatives, Vol. 19, No. 2, pp. 61-70, 2011
Number of pages: 16 Posted: 08 Jan 2012 Last Revised: 26 Dec 2012
Wells Fargo, Bates White, LLC, Securities Litigation and Consulting Group and Securities and Exchange Commission (SEC)
Downloads 79 (219,379)

Abstract:

Structured Products, Barrier Option, Absolute Return Barrier Notes, Principal Protected